Enovix Corp (ENVX) stock
Close on Nov 12, 2026Market cap $396.11MP/E –Yield –
Earnings
Enovix's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Enovix's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 28, 2026 | Feb 24, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 28, 2026 | Oct 13, 2026before the open | $11.00M | +37.5% | -$0.19 | -$0.14 | Release |
| Q2 FY2026ended Jul 5, 2026 | Aug 12, 2026after the close | $9.00M | +20.0% | -$0.20 | -$0.13 | Release |
| Q1 FY2026ended Apr 5, 2026 | May 13, 2026after the close | $7.60M | +49.0% | -$0.18 | – | Release |
| Q4 FY2025ended Dec 28, 2025 | Feb 25, 2026after the close | $11.30M | +16.5% | -$0.16 | – | Release |
| Q3 FY2025ended Sep 28, 2025 | Nov 5, 2025after the close | $8.00M | +86.0% | -$0.27 | -$0.14 | Release |
| Q2 FY2025ended Jun 29, 2025 | Jul 7, 2025before the open | $7.50M | +97.4% | – | – | Release |
| Q1 FY2025ended Mar 30, 2025 | Apr 30, 2025after the close | $5.10M | -3.8% | -$0.12 | -$0.15 | Release |
| Q4 FY2024ended Dec 29, 2024 | Feb 19, 2025after the close | $9.70M | +31.1% | -$0.20 | -$0.11 | Release |
| Q3 FY2024ended Sep 29, 2024 | Oct 29, 2024after the close | $4.30M | +2050.0% | -$0.30 | -$0.17 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 31, 2024after the close | $3.80M | – | $0.67 | $0.14 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 1, 2024after the close | $5.30M | +25138.1% | -$0.28 | -$0.31 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 20, 2024after the close | $7.40M | +572.7% | -$0.36 | -$0.28 | Release |
| Q3 FY2023ended Oct 1, 2023 | Nov 7, 2023after the close | $200.00K | – | -$0.29 | -$0.19 | Release |
| Q2 FY2023ended Jul 2, 2023 | Jul 26, 2023after the close | – | – | – | – | Release |
| Q1 FY2023ended Apr 2, 2023 | Apr 26, 2023after the close | $21.00K | – | -$0.47 | -$0.20 | Release |
| Q4 FY2022ended Jan 1, 2023 | Feb 22, 2023after the close | $1.10M | – | -$0.27 | -$0.19 | Release |
| Q3 FY2022ended Oct 2, 2022 | Nov 1, 2022after the close | – | – | -$0.53 | -$0.15 | Release |
| Q2 FY2022ended Jul 3, 2022 | Aug 10, 2022after the close | $5.10M | – | -$0.18 | -$0.13 | Release |
| Q1 FY2022ended Apr 3, 2022 | May 11, 2022after the close | – | – | -$0.16 | -$0.13 | Release |
| Q4 FY2021ended Jan 2, 2022 | Mar 3, 2022after the close | – | – | -$0.60 | – | Release |
| Q3 FY2021ended Oct 3, 2021 | Nov 8, 2021after the close | – | – | -$0.08 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 10, 2021after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Enovix guided for has been reported
Guidance vs results
The last range Enovix gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Non-GAAP net loss per share | -$0.17 – -$0.13 | -$0.14 | Within range |
| Q3 FY2026 | Revenue | $9.00M – $10.00M | $11.00M | Above range |
| Q3 FY2026 | Revenue growth | +13% – +25% | +37.5% | Above range |
| Q2 FY2026 | Non-GAAP net loss per share | -$0.17 – -$0.13 | -$0.13 | Within range |
| Q2 FY2026 | Revenue | $8.00M – $9.00M | $9.00M | Within range |
| Q1 FY2026 | Revenue | $6.50M – $7.50M | $7.60M | Above range |
| Q4 FY2025 | Revenue | $9.50M – $10.50M | $11.30M | Above range |
| Q2 FY2025 | Revenue | $4.50M – $6.50M | $7.50M | Above range |
| Q1 FY2025 | EPS (GAAP) | -$0.29 – -$0.23 | -$0.12 | Above range |
| Q1 FY2025 | non-GAAP EPS loss | -$0.21 – -$0.15 | -$0.15 | Within range |
| Q1 FY2025 | Revenue | $3.50M – $5.50M | $5.10M | Within range |
| Q4 FY2024 | EPS (GAAP) | -$0.29 – -$0.23 | -$0.20 | Above range |
| Q4 FY2024 | non-GAAP EPS loss | -$0.21 – -$0.15 | -$0.11 | Above range |
| Q4 FY2024 | Revenue | $8.00M – $10.00M | $9.70M | Within range |
| Q3 FY2024 | EPS (GAAP) | $0.30 – $0.36 | -$0.30 | Below range |
| Q3 FY2024 | non-GAAP EPS loss | $0.17 – $0.23 | -$0.17 | Below range |
| Q3 FY2024 | Revenue | $3.50M – $4.50M | $4.30M | Within range |
| Q2 FY2024 | non-GAAP EPS loss | $0.22 – $0.28 | $0.14 | Below range |
| Q2 FY2024 | Revenue | $3.00M – $4.00M | $3.80M | Within range |
| Q1 FY2024 | Non-GAAP EPS loss | $0.29 – $0.35 | -$0.31 | Below range |
| Q1 FY2024 | Revenue | $3.50M – $4.50M | $5.30M | Above range |
| Q4 FY2023 | Revenue | $3.00M – $4.00M | $7.40M | Above range |
Guidance history
Every forecast Enovix put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 12, 2026 | Capital expenditures | Q3 FY2026 | $8.00M – $12.00M | New |
| Aug 12, 2026 | Non-GAAP net loss per share | Q3 FY2026 | -$0.17 – -$0.13 | New |
| Aug 12, 2026 | Non-GAAP loss from operations | Q3 FY2026 | -$32.00M – -$29.00M | New |
| Aug 12, 2026 | revenue growth | Q3 FY2026 | +13% – +25% | New |
| Aug 12, 2026 | Revenue | Q3 FY2026 | $9.00M – $10.00M | New |
| May 13, 2026 | Capital expenditures | Q2 FY2026 | $9.00M – $13.00M | New |
| May 13, 2026 | Non-GAAP net loss per share | Q2 FY2026 | -$0.17 – -$0.13 | New |
| May 13, 2026 | Non-GAAP loss from operations | Q2 FY2026 | -$32.00M – -$29.00M | New |
| May 13, 2026 | Revenue | Q2 FY2026 | $8.00M – $9.00M | New |
| Feb 25, 2026 | Capital expenditures | Q1 FY2026 | $9.00M – $11.00M | New |
| Feb 25, 2026 | Non GAAP net loss per share | Q1 FY2026 | -$0.18 – -$0.14 | New |
| Feb 25, 2026 | Non GAAP loss from operations | Q1 FY2026 | -$32.00M – -$29.00M | New |
| Feb 25, 2026 | Revenue | Q1 FY2026 | $6.50M – $7.50M | New |
| Nov 5, 2025 | Capital expenditures | Q4 FY2025 | $9.00M – $12.00M | New |
| Nov 5, 2025 | Non-GAAP net loss per share | Q4 FY2025 | -$0.20 – -$0.16 | New |
| Nov 5, 2025 | Non-GAAP loss from operations | Q4 FY2025 | -$33.00M – -$30.00M | New |
| Nov 5, 2025 | Revenue | Q4 FY2025 | $9.50M – $10.50M | New |
| Apr 30, 2025 | Adjusted EBITDA loss | Q2 FY2025 | -$29.00M – -$23.00M | New |
| Apr 30, 2025 | Non-GAAP net loss 1 per share attributable to Enovix | Q2 FY2025 | -$0.21 – -$0.15 | New |
| Apr 30, 2025 | Non-GAAP operating loss | Q2 FY2025 | -$37.00M – -$31.00M | New |
| Apr 30, 2025 | Revenue | Q2 FY2025 | $4.50M – $6.50M | New |
| Feb 19, 2025 | adjusted EBITDA loss | Q1 FY2025 | -$27.00M – -$21.00M | New |
| Feb 19, 2025 | non-GAAP EPS loss | Q1 FY2025 | -$0.21 – -$0.15 | New |
| Feb 19, 2025 | GAAP EPS loss | Q1 FY2025 | -$0.29 – -$0.23 | New |
| Feb 19, 2025 | revenue | Q1 FY2025 | $3.50M – $5.50M | New |
| Oct 29, 2024 | adjusted EBITDA loss | Q4 FY2024 | -$25.00M – -$19.00M | New |
| Oct 29, 2024 | non-GAAP EPS loss | Q4 FY2024 | -$0.21 – -$0.15 | New |
| Oct 29, 2024 | GAAP EPS loss | Q4 FY2024 | -$0.29 – -$0.23 | New |
| Oct 29, 2024 | revenue | Q4 FY2024 | $8.00M – $10.00M | New |
| Jul 31, 2024 | adjusted EBITDA loss | Q3 FY2024 | $23.00M – $29.00M | New |
| Jul 31, 2024 | non-GAAP EPS loss | Q3 FY2024 | $0.17 – $0.23 | New |
| Jul 31, 2024 | GAAP EPS loss | Q3 FY2024 | $0.30 – $0.36 | New |
| Jul 31, 2024 | revenue | Q3 FY2024 | $3.50M – $4.50M | New |
| May 1, 2024 | adjusted EBITDA loss | Q2 FY2024 | $26.00M – $32.00M | New |
| May 1, 2024 | non-GAAP EPS loss | Q2 FY2024 | $0.22 – $0.28 | New |
| May 1, 2024 | revenue | Q2 FY2024 | $3.00M – $4.00M | New |
| Feb 20, 2024 | adjusted EBITDA loss | Q1 FY2024 | $24.00M – $31.00M | New |
| Feb 20, 2024 | Non-GAAP EPS loss | Q1 FY2024 | $0.29 – $0.35 | New |
| Feb 20, 2024 | revenue | Q1 FY2024 | $3.50M – $4.50M | New |
| Nov 7, 2023 | CapEx forecast | FY2023 | $65.00M | Lowered |
| Nov 7, 2023 | operational cash use forecast | FY2023 | $110.00M | Lowered |
| Nov 7, 2023 | revenue | Q4 FY2023 | $3.00M – $4.00M | New |
| Apr 26, 2023 | capital expenditures | FY2023 | $120.00M | Reaffirmed |
| Apr 26, 2023 | production | Q2 FY2023 | 18,000 | New |
| Apr 26, 2023 | produce cells | FY2023 | 180,000 | Reaffirmed |
| Apr 26, 2023 | cash operationally | FY2023 | $120.00M | Raised |
| Feb 22, 2023 | capital expenditures | FY2023 | $120.00M | New |
| Feb 22, 2023 | wearable-size cells | Q1 FY2023 | 9000 | New |
| Feb 22, 2023 | wearable-size cells at Fab-1 | FY2023 | 180,000 | New |
| Feb 22, 2023 | spend cash operationally | FY2023 | $120.00M | New |
| Feb 22, 2023 | increase in depreciation and amortization expense | FY2023 | $12.00M | Lowered |
| Nov 1, 2022 | cash use | FY2022 | $130.00M – $150.00M | Lowered |
| Nov 1, 2022 | cash | FY2022 | $300.00M | Raised |
| Nov 1, 2022 | revenue | FY2022 | $6.00M – $8.00M | Reaffirmed |
| Aug 10, 2022 | cash use | FY2022 | $160.00M – $180.00M | Lowered |
| Aug 10, 2022 | revenue | FY2022 | $6.00M – $8.00M | Lowered |
| May 11, 2022 | cash | FY2022 | $190.00M – $210.00M | Reaffirmed |
| May 11, 2022 | revenue | FY2022 | $6.00M – $12.00M | Reaffirmed |
| Mar 3, 2022 | cash | FY2022 | $190.00M – $210.00M | New |
| Mar 3, 2022 | revenue | FY2022 | $6.00M – $12.00M | New |
| Nov 8, 2021 | free cash flow | FY2021 | $110.00M – $120.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Enovix filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- News
- News
- Update
See a number that looks wrong?